Synapse

← Kwok‐Yung Yuen

Papers by Kwok‐Yung Yuen

Page 5 · newest first

  1. Infection control challenges in setting up community isolation and treatment facilities for patients with coronavirus disease 2019 (COVID-19): Implementation of directly observed environmental disinfectionInfection Control and Hospital Epidemiology · 2020
  2. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian HamstersClinical Infectious Diseases · 2020
  3. Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters2020
  4. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 InfectionClinical Chemistry and Laboratory Medicine (CCLM) · 2020
  5. Suppression of SARS‐CoV‐2 infection in ex‐vivo human lung tissues by targeting class III phosphoinositide 3‐kinaseJournal of Medical Virology · 2020
  6. Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenesNature Communications · 2020
  7. SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19Cellular and Molecular Gastroenterology and Hepatology · 2020
  8. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰EBioMedicine · 2020
  9. Serum Antibody Profile of a Patient With Coronavirus Disease 2019 ReinfectionClinical Infectious Diseases · 2020
  10. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian HamstersCell Reports Medicine · 2020
  11. Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody AssayInternational Journal of Molecular Sciences · 2020
  12. Human airway organoids model SARS-CoV-2 high infectiousness and evasion of interferon response2020
  13. Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotypingExpert Review of Molecular Diagnostics · 2020
  14. Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptationProceedings of the National Academy of Sciences · 2020
  15. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2Nature Communications · 2020
  16. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome SequencingClinical Infectious Diseases · 2020
  17. Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein2020
  18. Unique Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 Causing a Large Coronavirus Disease 2019 Outbreak in Hong KongClinical Infectious Diseases · 2020
  19. SARS-CoV-2 infects human neural progenitor cells and brain organoidsCell Research · 2020
  20. Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKεThe Journal of Immunology · 2020
  21. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingNature · 2020
  22. Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in Enterovirus-Infected CellsMetabolites · 2020
  23. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature · 2020
  24. Polyclonal Burkholderia cepacia Complex Outbreak in Peritoneal Dialysis Patients Caused by Contaminated Aqueous ChlorhexidineEmerging infectious diseases · 2020
  25. Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus InfectionFrontiers in Microbiology · 2020
  26. False-positive SARS-CoV-2 serology in 3 children with Kawasaki diseaseDiagnostic Microbiology and Infectious Disease · 2020
  27. Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of HamstersClinical Infectious Diseases · 2020
  28. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung2020
  29. Natural Transmission of Bat-like Severe Acute Respiratory Syndrome Coronavirus 2 Without Proline-Arginine-Arginine-Alanine Variants in Coronavirus Disease 2019 PatientsClinical Infectious Diseases · 2020
  30. Factors affecting stability and infectivity of SARS-CoV-2Journal of Hospital Infection · 2020
  31. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patientsCell Research · 2020
  32. A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on DialysisClinical Infectious Diseases · 2020
  33. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)Viruses · 2020
  34. Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virusPLoS Pathogens · 2020
  35. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort studyThe Lancet Microbe · 2020
  36. Early-Morning vs Spot Posterior Oropharyngeal Saliva for Diagnosis of SARS-CoV-2 Infection: Implication of Timing of Specimen Collection for Community-Wide ScreeningOpen Forum Infectious Diseases · 2020
  37. Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic ReviewOpen Forum Infectious Diseases · 2020
  38. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases · 2020
  39. Improved detection of antibody against SARS-CoV-2 by microsphere-based antibody assay2020
  40. Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes2020
  41. Risk of Hepatitis E among Persons Who Inject Drugs in Hong Kong: A Qualitative and Quantitative Serological AnalysisMicroorganisms · 2020
  42. Targeting the Inositol-Requiring Enzyme‑1 Pathway Efficiently Reverts Zika Virus-Induced Neurogenesis and Spermatogenesis Marker PerturbationsACS Infectious Diseases · 2020
  43. Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-192020
  44. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational studyThe Lancet Microbe · 2020
  45. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals2020
  46. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19Clinical Infectious Diseases · 2020
  47. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical SpecimensInternational Journal of Molecular Sciences · 2020
  48. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and TransmissibilityClinical Infectious Diseases · 2020
  49. A broad-spectrum virus- and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory viruses2020
  50. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical SpecimensJournal of Clinical Microbiology · 2020